Roxithromycin Ambroxol Tablets do not cure pharyngitis. It is clearly stated in the instructions of the drug that it is used for the treatment of bronchitis caused by a variety of reasons; at the same time, the symptoms of bronchitis and pharyngitis are different. Therefore, pharyngitis patients can not take Roxithromycin Ambroxol Tablets. This product is a compound preparation, in which roxithromycin can pass through the bacterial cell membrane, in close proximity to the donor and the bacterial ribosome 50s subunit is reversible binding, blocking the transfer of ribonucleic acid binding, thus inhibiting bacterial protein synthesis; aminobromine hydrochloride can increase the secretion of the respiratory mucosal plasma glands, reduce the secretion of the mucous glands, thus reducing the viscosity of sputum, so that sputum is easy to cough out. Clinically, the drug is used for bacterial acute bronchitis caused by sensitive bacteria, acute exacerbation of bronchitis, and bronchitis in the elderly that require expectorant treatment. After the use of the drug there are adverse reactions such as nausea, vomiting, epigastric pain, diarrhea, rash. Contraindicated in patients with hypersensitivity to macrolides, ambroxol, bromhexine; contraindicated in patients taking vasoconstrictor ergot alkaloids; contraindicated in pregnant and lactating women. Caution should be exercised in patients with hepatic insufficiency and history of gastric ulcer; the absorption of this product can be increased by taking it with milk. Patients with pharyngitis should go to the hospital in time to avoid delays.